Protagonist Therapeutics Inc (PTGX)
R&D Expenses
$175.16M
TTM · Period ending: · USD
PTGX R&D Expenses
Latest reported$175.16Mperiod ending
Latest reported$175.16Mperiod ending
PTGX TTM R&D Expenses ($11.83M → $175.16M)
TTM R&D Expenses
High-resolution chart · PNG
PTGX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 175,161,000 | |
| 170,136,000 | |
| 159,290,000 | |
| 147,836,000 | |
| 143,803,000 | |
| 140,287,000 | |
| 138,128,000 | |
| 132,123,000 | |
| 126,817,000 | |
| 126,479,000 | |
| 120,161,000 | |
| 121,146,000 | |
| 115,884,000 | |
| 117,313,000 | |
| 126,215,000 | |
| 135,604,000 | |
| 147,158,000 | |
| 139,964,000 | |
| 128,719,000 | |
| 109,572,000 | |
| 88,611,000 | |
| 81,451,000 | |
| 75,146,000 | |
| 70,931,000 | |
| 72,229,000 | |
| 71,327,000 | |
| 65,003,000 | |
| 63,340,000 | |
| 58,192,000 | |
| 56,572,000 | |
| 59,496,000 | |
| 56,972,000 | |
| 55,995,000 | |
| 50,267,000 | |
| 46,181,000 | |
| 43,280,000 | |
| 37,673,000 | |
| 31,362,000 | |
| 25,705,000 | |
| 21,075,000 | |
| 18,672,000 | |
| 15,273,000 | |
| 11,831,000 |